[Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
نویسندگان
چکیده
Cabergoline is a synthetic dopamine agonist used to treat Parkinson disease. The drug occasionally induces pleuropulmonary adverse effects, which manifest as pleural thickening or effusion, interstitial pneumonitis, pulmonary infiltrates, or fibrosis. We report a rare case of pleural effusion and severe pulmonary hypertension in a 79-year-old man with Parkinson disease who had been treated with cabergoline for 1 year. The symptoms disappeared 10 months after the drug was discontinued.
منابع مشابه
Spontaneous Hemothorax in a Patient with Neurofibromatosis Type 1: A Case Report
Background: Neurofibromatosis type1 (NF-1) is a hereditary autosomal dominant disease that is accompanied by complications, such as benign and malignant tumors and vascular involvement, including pulmonary hypertension, artery stenosis, and pulmonary artery aneurysm. Spontaneous hemothorax is a rare and lethal complication of NF-1 due to vasculopathy as stenosis or aneurysmal modifications of l...
متن کاملSevere pulmonary hypertension reversed by antibiotics in a patient with Whipple's disease.
The case is described of a 58 year old man with systemic Whipple's disease with pericardial and pleural effusions and severe pulmonary hypertension. After three months of antibiotic treatment there was a complete resolution, not only of the symptoms known to be associated with Whipple's disease (diarrhoea, arthralgia, pericardial and pleural effusions), but also of pulmonary hypertension.
متن کاملAn Experience From a Pleural Effusion Patient: A Rare Case of Coccidioidomycosis
Pulmonary coccidioidomycosis is an infection in the lungs caused by the fungus Coccidioides. The disease is very rare in India and only a few cases have been reported so far. The diagnosis of pulmonary coccidioidomycosis is very challenging because it mimics other lower respiratory tract infections. Both clinical suspicion and laboratory confirmation plays a very important role in the diagnosis...
متن کامل[Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug].
We report a case of pleural effusion, pericardial thickening, and pulmonary involvement in a patient with dry cough, dyspnea, edema, and changes in the skin of the lower limbs. Treatment with cabergoline (Sogilen) had been started 4 months earlier. Pleural effusion, pericardial thickening, and impaired pulmonary function (airflow obstruction, increased airway resistance, and reduced carbon mono...
متن کاملPleuropulmonary Toxicity of Another Anti-Parkinson’s Drug: Cabergoline
Many drugs may cause toxic injury to the lungs and the pleura. Cabergoline is an ergoline derivative which has been used in Spain for seven years to control symptoms of Parkinson's disease. We report a patient with dyspnea, bilateral pleural effusion and distal swelling. After a series of complementary tests (blood analysis, chest CT, echocardiogram, pleural tap, pleural biopsy), etiological sc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Archivos de bronconeumologia
دوره 45 2 شماره
صفحات -
تاریخ انتشار 2009